Classic versus non-classic receptors for nongenomic mineralocorticoid responses: emerging evidence

Ralf M Lösel1, Martin Wehling

  • 1Clinical Pharmacology Mannheim, University of Heidelberg, Mannheim, Germany.

Insights

Mineralocorticoids in the brain trigger genomic and nongenomic responses. Research is exploring the receptors mediating these nongenomic effects, with classic receptors showing new properties and novel membrane receptors emerging.

Area of Science:

  • Neuroendocrinology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Mineralocorticoids are produced both in the adrenal glands and centrally in the nervous system.
  • These hormones elicit both genomic and nongenomic cellular responses.
  • The central nervous system (CNS) functions of mineralocorticoids are increasingly recognized.

Purpose of the Study:

  • To review known functions of mineralocorticoids in the CNS.
  • To discuss nongenomic mineralocorticoid responses in various tissues.
  • To address the ongoing scientific debate surrounding the identity of receptors mediating nongenomic, transcription-independent steroid actions.

Main Methods:

  • Literature review of existing studies on mineralocorticoid actions.
  • Analysis of evidence supporting classic nuclear receptors versus novel membrane receptors for nongenomic effects.
  • Comparison of research tools available for studying classic versus alternative steroid receptors.

Main Results:

  • Classic nuclear receptors show evidence for mediating nongenomic steroid effects in some contexts.
  • Evidence for classic receptors is lacking in other instances, fueling interest in alternative receptors.
  • Recent discoveries highlight unexpected properties of classic receptors, shifting focus away from novel membrane receptors.

Conclusions:

  • The identity of receptors mediating nongenomic steroid responses remains a significant area of scientific inquiry.
  • Advancements in understanding classic receptor properties are influencing the search for novel receptors.
  • Clarifying receptor involvement is crucial for the medical translation of targeted steroid therapies.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...